Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis (IPF) is a chronically progressive interstitial lung that affects over 3 M people worldwide and rising in incidence. With a median survival of 2–3 years, IPF is consequently associated with high morbidity, mortality, and healthcare burden. Although two antifibrotic ther...
Main Authors: | Melissa Skibba, Adam Drelich, Michael Poellmann, Seungpyo Hong, Allan R. Brasier |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.607689/full |
Similar Items
-
Research progress of epigenetics in epilepsy
by: Wen-yue WU, et al.
Published: (2018-06-01) -
NONINVASIVE PARAMETERS AND STAGING OF LIVER FIBROSIS IN CHRONIC HEPATITIS C PATIENTS
by: Abdur Rahim, et al.
Published: (2019-03-01) -
Targeting inducible epigenetic reprogramming pathways in chronic airway remodeling
by: Allan R Brasier, et al.
Published: (2019-10-01) -
Systematic review of catatonia treatment
by: Pelzer ACM, et al.
Published: (2018-01-01) -
Macronutrients and Micronutrients in Parenteral Nutrition for Preterm Newborns: A Narrative Review
by: Valentina Rizzo, et al.
Published: (2022-04-01)